It has been shown that KRAS-G12D protein released from tumour cells undergoes ferrogenesis and is taken up by macrophages, leading to the conversion of macrophages to an M2-like suppressing-inflammatory pro-tumour phenotype (Janes et al., 2018). The gene discussed is KRAS; the disease is neoplasm.